Terms: = Bone cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
1008 results:
1. Contrast-Enhanced Ultrasonography in Diagnosing Intravascular Large B-Cell Lymphoma Infiltrating Liver Sinusoids.
Ota H; Nakayama S; Takeo H; Watanabe S; Masuoka K
Am J Case Rep; 2024 Apr; 25():e943070. PubMed ID: 38678318
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical Characteristics of CD4
He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871
[TBL] [Abstract] [Full Text] [Related]
3. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
[TBL] [Abstract] [Full Text] [Related]
4. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
[TBL] [Abstract] [Full Text] [Related]
5. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
[TBL] [Abstract] [Full Text] [Related]
6. An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
Shafat T; Grupel D; Porges T; Abuhasira R; Belkin A; Deri O; Oster Y; Zahran S; Horwitz E; Horowitz NA; Khatib H; Batista MV; Cortez AC; Brosh-Nissimov T; Segman Y; Ishay L; Cohen R; Atamna A; Spallone A; Chemaly RF; Ramos-Ramos JC; Chowers M; Rogozin E; Oren NC; Keske Ş; Barchad OW; Nesher L;
Cancer Med; 2024 Feb; 13(3):e6997. PubMed ID: 38400683
[TBL] [Abstract] [Full Text] [Related]
7. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
8. Characterizing Immune Infiltration in Esthesioneuroblastoma Subtypes Through Gene Expression Deconvolution.
Batchu S; Gill AS; Karsy M
World Neurosurg; 2024 Mar; 183():e928-e935. PubMed ID: 38246527
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical pathological and genetic mutation characteristics of conjunctival lymphoepithelial carcinoma].
Wang YC; Li J; Guo YT; Li J; Lin JY
Zhonghua Yan Ke Za Zhi; 2024 Jan; 60(1):64-71. PubMed ID: 38199770
[No Abstract] [Full Text] [Related]
11. Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma.
Bosch F; Kuruvilla J; Vassilakopoulos TP; Maio DD; Wei MC; Zumofen MB; Nastoupil LJ
Clin Lymphoma Myeloma Leuk; 2024 Feb; 24(2):105-121. PubMed ID: 37981564
[TBL] [Abstract] [Full Text] [Related]
12. Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial.
Ladetto M; Tavarozzi R; Zanni M; Evangelista A; Ferrero S; Tucci A; Botto B; Bolis S; Volpetti S; Zilioli VR; Puccini B; Arcari A; Pavone V; Gaidano G; Corradini P; Tani M; Cavallo F; Milone G; Ghiggi C; Pinto A; Pastore D; Ferreri AJM; Latte G; Patti C; Re F; Benedetti F; Luminari S; Pennese E; Bossi E; Boccomini C; Anastasia A; Bottelli C; Ciccone G; Vitolo U
Ann Oncol; 2024 Jan; 35(1):118-129. PubMed ID: 37922989
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
14. The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience.
Olszewska-Szopa M; Ożańska A; Ożański T; Rybka J; Wróbel T
Leuk Lymphoma; 2024 Jan; 65(1):55-61. PubMed ID: 37888870
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
16. Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia.
Hill BT; Ma S; Zent CS; Baran AM; Wallace DS; Advani A; Winter A; Winter J; Gordan L; Karmali R; Liesveld JL; Mulford DA; Rowland C; Bui A; Sportelli P; Miskin HP; Weiss MS; Friedberg JW; Barr PM
Blood Adv; 2024 Jan; 8(2):378-387. PubMed ID: 37871300
[TBL] [Abstract] [Full Text] [Related]
17. slan+ Monocytes Kill cancer Cells Coated in Therapeutic Antibody by Trogoptosis.
Finotti G; Pietronigro E; Balanzin C; Lonardi S; Constantin G; Chao MP; Tecchio C; Vermi W; Cassatella MA
Cancer Immunol Res; 2023 Nov; 11(11):1538-1552. PubMed ID: 37695535
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions.
Duminuco A; Nardo A; Orofino A; Giunta G; Conticello C; Del Fabro V; Chiarenza A; Parisi MS; Figuera A; Leotta S; Milone G; Cupri A; Cambria D; Di Raimondo F; Romano A; Palumbo GA
Cancer; 2024 Jan; 130(1):41-50. PubMed ID: 37658645
[TBL] [Abstract] [Full Text] [Related]
19. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level.
John L; Poos AM; Brobeil A; Schinke C; Huhn S; Prokoph N; Lutz R; Wagner B; Zangari M; Tirier SM; Mallm JP; Schumacher S; Vonficht D; Solé-Boldo L; Quick S; Steiger S; Przybilla MJ; Bauer K; Baumann A; Hemmer S; Rehnitz C; Lückerath C; Sachpekidis C; Mechtersheimer G; Haberkorn U; Dimitrakopoulou-Strauss A; Reichert P; Barlogie B; Müller-Tidow C; Goldschmidt H; Hillengass J; Rasche L; Haas SF; van Rhee F; Rippe K; Raab MS; Sauer S; Weinhold N
Nat Commun; 2023 Aug; 14(1):5011. PubMed ID: 37591845
[TBL] [Abstract] [Full Text] [Related]
20. From the archives of MD Anderson cancer Center: Sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression.
Siddiqui SH; Thakral B; Aakash F; Ok CY; Tang Z; Medeiros LJ
Ann Diagn Pathol; 2023 Oct; 66():152182. PubMed ID: 37543028
[TBL] [Abstract] [Full Text] [Related]
[Next]
